Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation
Open accessAbstract
The concept of implantable glucose sensors has been promulgated for more than 40 years. It is now accepted that continuous glucose monitoring (CGM) increases quality of life by allowing informed diabetes management decisions as a result of more optimized glucose control. The focus of this article is to provide a brief overview of the CGM market history, emerging technologies, and the foreseeable challenges for the next CGM generations as well as proposing possible solutions in an effort to advance the next generation of implantable sensor.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evaluating the correlation between the menstrual cycle and glycaemic control in type 1 diabetes has been challenging due to the need for intensive glucose monitoring, which has become accurate only in recent decades.
“the need for intensive glucose monitoring, which has become accurate only in recent decades thanks to the implementation of flash and continuous glucose monitoring systems [2]”
From Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review (2023) · cites this paper as [2]
The citation lists haven’t been fetched yet
References 49 · Cited by 175
- Authors
- Didyuk, O., Econom, N., Guardia, A., Livingston, K., & Klueh, U.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Klueh, Ulrike
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-01-13
- Volume
- 15
- Issue
- 3
- Pages
- 676-683
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC8120065
- OpenAlex
- W2999666543
- Cited by
- 175
- References
- 49
- Citations by year
- 2026: 26 · 2025: 45 · 2024: 39 · 2023: 35 · 2022: 16 · 2021: 8 · 2020: 6
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Engineering › Electrical and Electronic Engineering › Electrochemical sensors and biosensors
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- continuous glucose monitoring, implantable glucose sensor, diabetes management, glycemic control, technological innovation
- MeSH terms
- Blood Glucose, Humans, Insulin Infusion Systems, Quality of Life, Blood Glucose Self-Monitoring, Inventions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
